Mark Cannon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mark Cannon has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Awan A
Ann and Robert Lurie Children’s Hospital of Chicago, Chicago, United States
2 shared publicationsJantra L
Ann and Robert Lurie Children’s Hospital of Chicago, Chicago, United States
2 shared publicationsKabat B
Ann and Robert Lurie Children’s Hospital of Chicago, Chicago, United States
2 shared publicationsMari Tesch
Aventura Hospital Pulmonary and Critical Care Fellowship, Aventura, FL 33180, USA
2 shared publications- Matthew John Schipma
Northwestern University Feinberg School of Medicine, Department of Medicine, Chicago, United States, USA
2 shared publications Vorachek A
Ann and Robert Lurie Children’s Hospital of Chicago, Chicago, United States
2 shared publications
Latest Publications
- Open Access
- 10 January 2025
- Published by MDPI AG in Nutraceuticals
- Vol. 5 (1) , 4
Effects of Xylitol on Tumor Progression in Syngeneic Mice Cancer Models
This study investigates the effects of xylitol, a natural sugar alcohol, on tumor progression in syngeneic mouse cancer models. Xylitol is known for its dental health benefits, but emerging evidence suggests broader biological roles, including potential anti-cancer properties. We explored xylitol’s impact on two mouse cancer models: 4T1 mammary carcinoma and B16F10 melanoma. Xylitol’s efficacy in inhibiting cancer cell lines and modulating tumor progression was assessed using immunocompetent female mice. The experiments involved intratumoral and peritumoral administration of a 20% xylitol solution in two mouse strains: BALB/c (4T1 mammary carcinoma) and C57BL/6 (B16F10 melanoma). Tumor volume, histopathology, and metabolomic analyses were conducted to gauge xylitol’s influence. The study revealed that xylitol administration initially reduced tumor growth in the B16F10 melanoma model, accompanied by alterations in tumor metabolism. However, similar effects were not observed in the 4T1 mammary carcinoma model, and melanoma tumor growth re-commenced in the melanoma model after stroma deterioration caused xylitol solution leakage. These findings suggest that xylitol may have potential as an adjunct therapy in cancer treatment, specifically in melanoma. The differential response between the two cancer models underscores the complexity of cancer biology and the need for further investigation into xylitol’s mechanisms of action and its role in cancer therapy.
- 10 January 2025
- Published by MDPI AG in Nutraceuticals
- Vol. 5 (1) , 4
Open AccessEffects of Xylitol on Tumor Progression in Syngeneic Mice Cancer Models
This study investigates the effects of xylitol, a natural sugar alcohol, on tumor progression in syngeneic mouse cancer models. Xylitol is known for its dental health benefits, but emerging evidence suggests broader biological roles, including potential anti-cancer properties. We explored xylitol’s impact on two mouse cancer models: 4T1 mammary carcinoma and B16F10 melanoma. Xylitol’s efficacy in inhibiting cancer cell lines and modulating tumor progression was assessed using immunocompetent female mice. The experiments involved intratumoral and peritumoral administration of a 20% xylitol solution in two mouse strains: BALB/c (4T1 mammary carcinoma) and C57BL/6 (B16F10 melanoma). Tumor volume, histopathology, and metabolomic analyses were conducted to gauge xylitol’s influence. The study revealed that xylitol administration initially reduced tumor growth in the B16F10 melanoma model, accompanied by alterations in tumor metabolism. However, similar effects were not observed in the 4T1 mammary carcinoma model, and melanoma tumor growth re-commenced in the melanoma model after stroma deterioration caused xylitol solution leakage. These findings suggest that xylitol may have potential as an adjunct therapy in cancer treatment, specifically in melanoma. The differential response between the two cancer models underscores the complexity of cancer biology and the need for further investigation into xylitol’s mechanisms of action and its role in cancer therapy.
- Open Access
- 12 July 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (7) , 1407
Whole-Genome Deep Sequencing of the Healthy Adult Nasal Microbiome
This study aimed to determine shifts in microbial populations regarding richness and diversity from the daily use of a popular over-the-counter nasal spray. In addition, the finding of nasal commensal bacterial species that overlap with the oral microbiome may prove to be potential probiotics for the “gateway microbiomes”. Nasal swab samples were obtained before and after using the most popular over-the-counter (OTC) nasal spray in 10 participants aged 18–48. All participants were healthy volunteers with no significant medical histories. The participants were randomly assigned a number by randomizing software and consisted of five men and five women. The sampling consisted of placing a nasal swab atraumatically into the nasal cavity. The samples were preserved and sent to Northwestern University Sequencing Center for whole-genome deep sequencing. After 21 days of OTC nasal spray use twice daily, the participants returned for further nasal microbiome sampling. The microbial analysis included all bacteria, archaea, viruses, molds, and yeasts via deep sequencing for species analysis. The Northwestern University Sequencing Center utilized artificial intelligence analysis to determine shifts in species and strains following nasal spray use that resulted in changes in diversity and richness.
- 12 July 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (7) , 1407
Open AccessWhole-Genome Deep Sequencing of the Healthy Adult Nasal Microbiome
This study aimed to determine shifts in microbial populations regarding richness and diversity from the daily use of a popular over-the-counter nasal spray. In addition, the finding of nasal commensal bacterial species that overlap with the oral microbiome may prove to be potential probiotics for the “gateway microbiomes”. Nasal swab samples were obtained before and after using the most popular over-the-counter (OTC) nasal spray in 10 participants aged 18–48. All participants were healthy volunteers with no significant medical histories. The participants were randomly assigned a number by randomizing software and consisted of five men and five women. The sampling consisted of placing a nasal swab atraumatically into the nasal cavity. The samples were preserved and sent to Northwestern University Sequencing Center for whole-genome deep sequencing. After 21 days of OTC nasal spray use twice daily, the participants returned for further nasal microbiome sampling. The microbial analysis included all bacteria, archaea, viruses, molds, and yeasts via deep sequencing for species analysis. The Northwestern University Sequencing Center utilized artificial intelligence analysis to determine shifts in species and strains following nasal spray use that resulted in changes in diversity and richness.
- Open Access
- 28 May 2024
- Published by MDPI AG in Preprints.org
Whole-Genome Deep Sequencing of the Healthy Adult Nasal Microbiome
This study aimed to determine shifts in microbial populations regarding richness and diversity from the daily use of a popular over-the-counter nasal spray. In addition, the finding of nasal commensal bacterial species that overlap with the oral microbiome may prove to be potential probiotics for the “gateway microbiomes.” Nasal swab samples were obtained before and after using the most popular over-the-counter (OTC) nasal spray in 10 participants aged 18–48. All participants were healthy volunteers with no significant medical histories. The participants were randomly assigned a number by randomizing software and consisted of five men and five women. The sampling consisted of placing a nasal swab atraumatically into the nasal cavity. The samples were preserved and sent to Northwestern University Sequencing Center for whole-genome deep sequencing. After 21 days of OTC nasal spray use twice daily, the participants returned for further nasal microbiome sampling. The microbial analysis included all bacteria, archaea, viruses, molds, and yeasts via deep sequencing for species analysis. The Northwestern University Sequencing Center utilized artificial intelligence analysis to determine shifts in species and strains following nasal spray use that resulted in changes in diversity and richness.
- 28 May 2024
- Published by MDPI AG in Preprints.org
Open AccessWhole-Genome Deep Sequencing of the Healthy Adult Nasal Microbiome
This study aimed to determine shifts in microbial populations regarding richness and diversity from the daily use of a popular over-the-counter nasal spray. In addition, the finding of nasal commensal bacterial species that overlap with the oral microbiome may prove to be potential probiotics for the “gateway microbiomes.” Nasal swab samples were obtained before and after using the most popular over-the-counter (OTC) nasal spray in 10 participants aged 18–48. All participants were healthy volunteers with no significant medical histories. The participants were randomly assigned a number by randomizing software and consisted of five men and five women. The sampling consisted of placing a nasal swab atraumatically into the nasal cavity. The samples were preserved and sent to Northwestern University Sequencing Center for whole-genome deep sequencing. After 21 days of OTC nasal spray use twice daily, the participants returned for further nasal microbiome sampling. The microbial analysis included all bacteria, archaea, viruses, molds, and yeasts via deep sequencing for species analysis. The Northwestern University Sequencing Center utilized artificial intelligence analysis to determine shifts in species and strains following nasal spray use that resulted in changes in diversity and richness.
- Open Access
- 13 July 2020
- Published by Edelweiss Publications Inc in Edelweiss Journal of Biomedical Research and Review
- p. 24-30
Pilot study of the SCFA Headspace Analysis of Streptococcus mutans Metabolites in Media with and without Polyols
This pilot study of Streptococcus mutans ATCC 35668 grown in media with and without polyols (erythritol) measured the resultant metabolites, including the Short Chain Fatty Acids (SCFA) by using head space analysis. Brain Heart Infusion Broth (BHI2 or BHI10) supplemented with 2% or 10% sucrose containing no polyols or either erythritol or xylitol and Streptococcus mutans (ATCC 35668) was grown aerobically. After 48 hours of growth the supernatant were harvested and centrifuged to pellet bacteria. Supernatants were removed from bacterial pellets then submitted for SCFA analysis with an Agilent Technologies (Santa Clara, CA 95051) system configured from three components, a 5973-mass selective detector, a 6890N gas chromatographer, and a 7697A headspace sampler. Streptococcus mutans growing in BHI supplemented with 2% or 10% sucrose but containing no polyols produced the following short chain fatty acids: methyl isovalerate, acetic acid, propionic acid, butanoic acid, pentanoic acid, ethyl butaric acid, 4-methylvaleric acid, hexanoic acid. When the BHI broth supplemented with 2% or 10% sucrose containing erythritol was used as media for this Streptococcus mutans strain, the following were produced: ethanol, acetoin, and acetic acid. Our results would indicate that constituents of the bacteria media may affect the bacterial metabolite production.
- 13 July 2020
- Published by Edelweiss Publications Inc in Edelweiss Journal of Biomedical Research and Review
- p. 24-30
Open AccessPilot study of the SCFA Headspace Analysis of Streptococcus mutans Metabolites in Media with and without Polyols
This pilot study of Streptococcus mutans ATCC 35668 grown in media with and without polyols (erythritol) measured the resultant metabolites, including the Short Chain Fatty Acids (SCFA) by using head space analysis. Brain Heart Infusion Broth (BHI2 or BHI10) supplemented with 2% or 10% sucrose containing no polyols or either erythritol or xylitol and Streptococcus mutans (ATCC 35668) was grown aerobically. After 48 hours of growth the supernatant were harvested and centrifuged to pellet bacteria. Supernatants were removed from bacterial pellets then submitted for SCFA analysis with an Agilent Technologies (Santa Clara, CA 95051) system configured from three components, a 5973-mass selective detector, a 6890N gas chromatographer, and a 7697A headspace sampler. Streptococcus mutans growing in BHI supplemented with 2% or 10% sucrose but containing no polyols produced the following short chain fatty acids: methyl isovalerate, acetic acid, propionic acid, butanoic acid, pentanoic acid, ethyl butaric acid, 4-methylvaleric acid, hexanoic acid. When the BHI broth supplemented with 2% or 10% sucrose containing erythritol was used as media for this Streptococcus mutans strain, the following were produced: ethanol, acetoin, and acetic acid. Our results would indicate that constituents of the bacteria media may affect the bacterial metabolite production.
- Open Access
- 7 February 2020
- Published by Edelweiss Publications Inc in Edelweiss Journal of Biomedical Research and Review
- p. 1-4
Investigation into Gluten Metabolizing Bacterial Species and their Inhibition
Environmental sources and domestic pets’ oral microbiomes were sampled for the presence of gluten metabolizing bacteria. Isolated bacteria were grown on gluten agar and challenged with Over The Counter (OTC) oral hygiene products and bacterial antagonistic bacteriocins to discover strains of gluten metabolizing bacteria that could potentially be utilized as a probiotic. Sixteen strains were isolated that were gluten metabolizers but only one strain was significantly more resistant to OTC oral hygiene products and to antagonistic bacterial bacteriocins. This newly isolated commensal strain may prove to be a potent gluten metabolizing probiotic. The oral microbiomes of household pets were not a significant source of gluten metabolizers.
- 7 February 2020
- Published by Edelweiss Publications Inc in Edelweiss Journal of Biomedical Research and Review
- p. 1-4
Open AccessInvestigation into Gluten Metabolizing Bacterial Species and their Inhibition
Environmental sources and domestic pets’ oral microbiomes were sampled for the presence of gluten metabolizing bacteria. Isolated bacteria were grown on gluten agar and challenged with Over The Counter (OTC) oral hygiene products and bacterial antagonistic bacteriocins to discover strains of gluten metabolizing bacteria that could potentially be utilized as a probiotic. Sixteen strains were isolated that were gluten metabolizers but only one strain was significantly more resistant to OTC oral hygiene products and to antagonistic bacterial bacteriocins. This newly isolated commensal strain may prove to be a potent gluten metabolizing probiotic. The oral microbiomes of household pets were not a significant source of gluten metabolizers.
- Open Access
- 5 February 2020
- Published by Edelweiss Publications Inc in Edelweiss: Psychiatry Open Access
- p. 5-8
Inhibition of Rothia Species by Over-the-Counter Products and Bacterial Antagonists
The interaction between the human host micro biome and over the counter products has recently been investigated, with surprising results. Some over the counter items may negatively affect the health of the host, supporting the concept of the “hygiene hypothesis”, that is, that disease may be actually caused by the lack of beneficial commensal bacteria. Recent reports on the gluten metabolizing genus, Rothia, and a possible association with Celiac Disease beg the question, what happened to the Rothia? In this study inhibitory factors, such as, Over The Counter oral hygiene products and antagonistic bacteria were investigated and, in vitro, significantly inhibited the gluten metabolizing bacteria, possibly affecting human digestion and contributing to gluten sensitivity.
- 5 February 2020
- Published by Edelweiss Publications Inc in Edelweiss: Psychiatry Open Access
- p. 5-8
Open AccessInhibition of Rothia Species by Over-the-Counter Products and Bacterial Antagonists
The interaction between the human host micro biome and over the counter products has recently been investigated, with surprising results. Some over the counter items may negatively affect the health of the host, supporting the concept of the “hygiene hypothesis”, that is, that disease may be actually caused by the lack of beneficial commensal bacteria. Recent reports on the gluten metabolizing genus, Rothia, and a possible association with Celiac Disease beg the question, what happened to the Rothia? In this study inhibitory factors, such as, Over The Counter oral hygiene products and antagonistic bacteria were investigated and, in vitro, significantly inhibited the gluten metabolizing bacteria, possibly affecting human digestion and contributing to gluten sensitivity.
- 1 October 2019
- Published by MRE Press in Journal of Clinical Pediatric Dentistry
- Vol. 43 (6) , 367-371
Retrospective Review of Oral Probiotic Therapy
Purpose: There have been many in vitro studies reporting on the efficacy of probiotic bacteria in inhibiting pathogens, and there have been published studies reporting on the inhibitor effects of probiotic bacteria on the salivary levels of bacterial pathogens. However, there have not been but a few studies on the clinical benefits of oral probiotic therapy. Study design: Dental records of 60 patients that were enrolled in an Institutional Review Board approved study were reviewed as to current caries activity status with measurement of the Decayed Missing Filled Teeth index and by Caries Management By Risk Assessment (CAMBRA) determination. The current oral health status was compared to the prior-to-study enrollment status and then analyzed in respect to published national norms.The data (without any identifiers) had a statistical analysis by a blinded biostatistician. The data was subjected to statistical analysis (Statsgraphic) before and after the probiotic therapy. Results: Of the 53 subjects available for follow up, only 4 had remained caries active with a grand total of 27 carious lesions being detected and subsequently restored in this group. Of the original total of 60 patients with 292 initial carious lesions, after probiotic therapy and dental restoration, 78 total restorations were placed in the subject group over the following three years. Approximately half of these restorations were required in teeth that had initially presented with smaller lesions and had been placed in a “watch” category. Two of the patients that developed further carious lesions had been randomly assigned to the probiotic PerioBalance, while the other two caries active patients were assigned EvoraKids probiotic.Of the original group of caries active patients, 24 did not present with any further carious involvement. Another 25 could be categorized as caries static, as the restorations required were substantially less than before probiotic therapy had been begun. The F-ratio, which in this case equals 51.3313, is a ratio of the between-group estimate to the within-group estimate. Since the P-value of the F-test is less than 0.05, there is a statistically significant difference between the means of the 4 variables at the 95.0% confidence level. Conclusion: The tested probiotic supplements had a statistically significant effect on the caries experience of the enrolled subjects.
- 1 October 2019
- Published by MRE Press in Journal of Clinical Pediatric Dentistry
- Vol. 43 (6) , 367-371
Retrospective Review of Oral Probiotic Therapy
Purpose: There have been many in vitro studies reporting on the efficacy of probiotic bacteria in inhibiting pathogens, and there have been published studies reporting on the inhibitor effects of probiotic bacteria on the salivary levels of bacterial pathogens. However, there have not been but a few studies on the clinical benefits of oral probiotic therapy. Study design: Dental records of 60 patients that were enrolled in an Institutional Review Board approved study were reviewed as to current caries activity status with measurement of the Decayed Missing Filled Teeth index and by Caries Management By Risk Assessment (CAMBRA) determination. The current oral health status was compared to the prior-to-study enrollment status and then analyzed in respect to published national norms.The data (without any identifiers) had a statistical analysis by a blinded biostatistician. The data was subjected to statistical analysis (Statsgraphic) before and after the probiotic therapy. Results: Of the 53 subjects available for follow up, only 4 had remained caries active with a grand total of 27 carious lesions being detected and subsequently restored in this group. Of the original total of 60 patients with 292 initial carious lesions, after probiotic therapy and dental restoration, 78 total restorations were placed in the subject group over the following three years. Approximately half of these restorations were required in teeth that had initially presented with smaller lesions and had been placed in a “watch” category. Two of the patients that developed further carious lesions had been randomly assigned to the probiotic PerioBalance, while the other two caries active patients were assigned EvoraKids probiotic.Of the original group of caries active patients, 24 did not present with any further carious involvement. Another 25 could be categorized as caries static, as the restorations required were substantially less than before probiotic therapy had been begun. The F-ratio, which in this case equals 51.3313, is a ratio of the between-group estimate to the within-group estimate. Since the P-value of the F-test is less than 0.05, there is a statistically significant difference between the means of the 4 variables at the 95.0% confidence level. Conclusion: The tested probiotic supplements had a statistically significant effect on the caries experience of the enrolled subjects.
- Open Access
- 21 June 2019
- Published by Edelweiss Publications Inc in Dental Research and Management
- p. 32-37
The Prevention and Treatment of Neural Arterial Gingival Simplex
Neural Arterial Gingival Simplex is a common systemic disease linked to an invasive periodontal pathogen, Porphyromonas gingivalis as the key initiator. Instead of considering separate pathologic conditions as separate diseases, the health community should view this disease as a single entity, to diagnose and treat accordingly. We discuss the evidence for this hypothesis and the need for definitive research. A strategy to maintain a healthy, resilient microbiome with adjunctive support by probiotics and polyols is warranted. Newer diagnostic and monitoring technologies along with many possible therapeutic agents and protocols are readily available to prevent and treat Neural Arterial Gingival Simplex.
- 21 June 2019
- Published by Edelweiss Publications Inc in Dental Research and Management
- p. 32-37
Open AccessThe Prevention and Treatment of Neural Arterial Gingival Simplex
Neural Arterial Gingival Simplex is a common systemic disease linked to an invasive periodontal pathogen, Porphyromonas gingivalis as the key initiator. Instead of considering separate pathologic conditions as separate diseases, the health community should view this disease as a single entity, to diagnose and treat accordingly. We discuss the evidence for this hypothesis and the need for definitive research. A strategy to maintain a healthy, resilient microbiome with adjunctive support by probiotics and polyols is warranted. Newer diagnostic and monitoring technologies along with many possible therapeutic agents and protocols are readily available to prevent and treat Neural Arterial Gingival Simplex.